From Self-sufficiency
Jump to: navigation, search
File:Alaproclate structure.svg
Systematic (IUPAC) name
1-(4-chlorophenyl)-2-methylpropan-2-yl 2-aminopropanoate
Clinical data
Routes of
Legal status
Legal status
  • Uncontrolled
CAS Number 60719-82-6
60719-83-7 (hydrochloride)
ATC code N06AB07 (WHO)
PubChem CID 2081
ChemSpider 1997
Chemical data
Formula C13H18ClNO2
Molar mass 255.740 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Alaproclate (GEA-654) is a psychoactive drug and research chemical derived from zimelidine (Normud, Zelmid) that was being developed as an antidepressant by the Swedish pharmaceutical company Astra AB (now AstraZeneca) in the 1970s. It acts as a selective serotonin reuptake inhibitor (SSRI), and along with zimelidine and indalpine, was one of the first of its kind. Development was discontinued due to the observation of liver complications in rodent studies.

See also


Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />